Recurrent Meningioma

Oncology·MeSH: Meningioma

Prevalence

5.0 / 100K

0 drugs in development·0 companies·4 clinical trials

Frequently asked questions

How many clinical trials target Recurrent Meningioma?

There are 4 clinical trials targeting Recurrent Meningioma tracked by BioSniper.

What is the prevalence of Recurrent Meningioma?

The estimated prevalence of Recurrent Meningioma is approximately 5.0 per 100,000 population.

Deep-dive into Recurrent Meningioma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Recurrent Meningioma — Drugs in Development & Clinical Trials | BioSniper